QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
Log in
CVE:EPI

ESSA Pharma Inc. (EPI.V) Stock Forecast, Price & News

C$8.20
+0.55 (+7.19 %)
(As of 10/30/2020)
Add
Compare
Today's Range
C$7.33
Now: C$8.20
C$8.20
50-Day Range
C$8.20
MA: C$8.20
C$8.20
52-Week Range
C$4.00
Now: C$8.20
C$11.34
Volume1,430 shs
Average Volume4,834 shs
Market CapitalizationC$237.87 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.

MarketRank

Overall MarketRank

0.56 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-778-3310962
Employees25
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Cash FlowC$2.33 per share
Book ValueC$2.47 per share

Profitability

Miscellaneous

Market CapC$237.87 million
Next Earnings DateN/A
OptionableOptionable
C$8.20
+0.55 (+7.19 %)
(As of 10/30/2020)
30 days | 90 days | 365 days | Advanced Chart

Receive EPI News and Ratings via Email

Sign-up to receive the latest news and ratings for EPI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











ESSA Pharma Inc. (EPI.V) (CVE:EPI) Frequently Asked Questions

How has ESSA Pharma Inc. (EPI.V)'s stock price been impacted by COVID-19 (Coronavirus)?

ESSA Pharma Inc. (EPI.V)'s stock was trading at C$5.56 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, EPI stock has increased by 47.5% and is now trading at C$8.20.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than ESSA Pharma Inc. (EPI.V)?

Wall Street analysts have given ESSA Pharma Inc. (EPI.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but ESSA Pharma Inc. (EPI.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Is ESSA Pharma Inc. (EPI.V) a good dividend stock?

ESSA Pharma Inc. (EPI.V) pays an annual dividend of C$0.22 per share and currently has a dividend yield of 0.00%.
View ESSA Pharma Inc. (EPI.V)'s dividend history.

Who are some of ESSA Pharma Inc. (EPI.V)'s key competitors?

What other stocks do shareholders of ESSA Pharma Inc. (EPI.V) own?

Who are ESSA Pharma Inc. (EPI.V)'s key executives?

ESSA Pharma Inc. (EPI.V)'s management team includes the following people:
  • Dr. David Ross Parkinson, Pres, CEO & Director (Age 71, Pay $626.81k)
  • Mr. David S. Wood C.M.A., CPA, M.B.A., MBA, CPA, CMA, Chief Financial Officer (Age 64, Pay $311.52k)
  • Mr. Peter A. Virsik M.B.A., M.S., Exec. VP & COO (Age 50, Pay $544.66k)
  • Dr. Alessandra Cesano, Chief Medical Officer
  • Chandtip Chandhasin, Exec.
  • Erica Osbourne, Exec.
  • Erin Rudsinski, Exec.
  • Leah Dimascio, Exec.
  • Loleta Harris, Exec.
  • Neil Thapar, Exec.

What is ESSA Pharma Inc. (EPI.V)'s stock symbol?

ESSA Pharma Inc. (EPI.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "EPI."

How do I buy shares of ESSA Pharma Inc. (EPI.V)?

Shares of EPI and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is ESSA Pharma Inc. (EPI.V)'s stock price today?

One share of EPI stock can currently be purchased for approximately C$8.20.

How big of a company is ESSA Pharma Inc. (EPI.V)?

ESSA Pharma Inc. (EPI.V) has a market capitalization of C$237.87 million. ESSA Pharma Inc. (EPI.V) employs 25 workers across the globe.

What is ESSA Pharma Inc. (EPI.V)'s official website?

The official website for ESSA Pharma Inc. (EPI.V) is essapharmaceuticals.com.

How can I contact ESSA Pharma Inc. (EPI.V)?

ESSA Pharma Inc. (EPI.V)'s mailing address is 999 Broadway W Suite 720, VANCOUVER, BC V5Z 1K5, Canada. The company can be reached via phone at +1-778-3310962.

This page was last updated on 1/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.